Table 1A.

External validation of CTCL progression-associated genes in two pooled independent cohorts of Sézary patients with RNA-Sequencing gene expression data (Ungewickell et al., Choi et al.).

Genes	Ratio mean TPM SS/ mean TPM Control	Fraction Genes with TPM > GOI – Control	Fraction Genes with TPM > GOI – SS	Corrected p-value
TOX	5.38	0.1896	0.1123	< 10−5
FYB	1.90	0.0429	0.0288	0.004
CD52	1.99	0.0017	0.0007	< 10−5
CCR4	3.56	0.0735	0.0231	< 10−5

TPM = Transcripts per Million, GOI = Gene-Of-Interest (Tested gene), SS = Sézary Syndrome.